"United Heart & Vascular Clinic offers a full range of resources for the prevention, early detection, rapid treatment and rehabilitation of heart disease in one integrated, state-of-the-art facility conveniently located in downtown St. Paul. Together with Nasseff Heart Center on the United Hospital Campus, United Heart & Vascular Clinic is your resource for specialty heart care."

During the past decade, United Heart and Vascular Clinic conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 18 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 9 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "United Heart and Vascular Clinic" #1 sponsor was "Boston Scientific Corporation" with 9 trials, followed by "Medtronic Cardiac Rhythm and Heart Failure" with 5 trials sponsored, "St. Paul Heart Clinic" with 5 trials sponsored, "Alan J. Bank, MD" with 2 trials sponsored and "Allina Health System" with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "United Heart and Vascular Clinic" #1 collaborator was "GlaxoSmithKline" with 4 trials as a collaborator, "Medtronic" with 4 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Daiichi Sankyo, Inc." with 2 trials as a collaborator and "The Cleveland Clinic" with 2 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "United Heart and Vascular Clinic" are "Heart Failure" (9 trials), "Coronary Artery Disease" (5 trials), "Atrial Fibrillation" (4 trials), "Hypertension" (4 trials) and "Congestive Heart Failure" (3 trials). Many other conditions were trialed in "United Heart and Vascular Clinic" in a lesser frequency.

Most popular intervention types in "United Heart and Vascular Clinic" are "Device" (25 trials), "Drug" (20 trials), "Other" (4 trials), "Diagnostic Test" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Darusentan" (2 trials), "Guanfacine" (2 trials), "Placebo" (2 trials), "ACUITY X4 quadripolar coronary venous lead and RELIANCE 4-FRONT defibrillation lead" (1 trials) and "AGI-1067" (1 trials). Other intervention names were less common.

The vast majority of trials in "United Heart and Vascular Clinic" are 49 trials for "All" genders.

Currently, there are NaN active trials in "United Heart and Vascular Clinic". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in United Heart and Vascular Clinic, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in United Heart and Vascular Clinic, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 11 trials that are defined as “Not Applicable".